Agenus Inc Share Price Today: Live Updates & Key Insights
Agenus Inc share price today is $5.94, up -3.39%. The stock opened at $6.195 against the previous close of $6.19, with an intraday high of $6.23 and low of $5.81.
Agenus Inc Share Price Chart
Agenus Inc Share Price Performance
Agenus Inc Institutional Holdings
Agenus Inc Market Status
Agenus Inc Fundamentals
Market Cap 257.77 M
PB Ratio 218.6149
PE Ratio 2.7031
Enterprise Value 236.36 M
Total Assets 226.80 M
Volume 1249283
Agenus Inc Company Financials
About Agenus Inc & investment objective
Company Information Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, a programmed death receptor-1 (PD-1) blocking antibody; AGEN1181, a human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody that is in Phase 2 trials in metastatic colorectal cancer (mCRC), pancreatic cancer, and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in clinical development; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monoclonal antibodies; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; and AGEN1884. The company operates under the Agenus, MiNK, Prophage, Retrocyte Display, and STIMULON trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., UroGen Pharma Ltd., Gilead Sciences, Inc., Incyte Corporation, and Merck Sharp & Dohme. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
Organisation Biotechnology
Employees 81
Industry Biotechnology
CEO Dr. Jennifer S. Buell Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Agenus Inc FAQs
What is the share price of Agenus Inc today?
The current share price of Agenus Inc is $5.94.
Can I buy Agenus Inc shares in India?
Yes, Indian investors can buy Agenus Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Agenus Inc shares in India?
You can easily invest in Agenus Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Agenus Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Agenus Inc.
Can I buy fractional shares of Agenus Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Agenus Inc?
Agenus Inc has a market cap of $257.77 M.
In which sector does Agenus Inc belong?
Agenus Inc operates in the Biotechnology sector.
What documents are required to invest in Agenus Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Agenus Inc?
The PE ratio of Agenus Inc is 2.70 and the PB ratio is 218.61.